Overview
Robert Alter is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Alter is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Urothelial Cancer, Endoscopy, and Nephrectomy. Dr. Alter is currently accepting new patients.
His clinical research consists of co-authoring 11 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
92 2nd St, Hackensack, NJ 07601
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
13 Clinical Trials
New York University
Zujun Li is an Oncologist and a Hematologist in New York, New York. Dr. Li is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Glioma, Laryngeal Cancer, Colorectal Cancer, and Throat Cancer.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Yale University
Harold Tara is an Oncologist and a Hematologist in Trumbull, Connecticut. Dr. Tara is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Urothelial Cancer, Muscle Invasive Bladder Cancer, Familial Prostate Cancer, and Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Renal Cell Carcinoma (RCC)
- Distinguished
- Adenoid Cystic CarcinomaDr. Alter isDistinguished. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Alter isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Alter isDistinguished. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Alter isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Alter isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Alter isDistinguished. Learn about Familial Prostate Cancer.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- AgranulocytosisDr. Alter isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- ChoriocarcinomaDr. Alter isAdvanced. Learn about Choriocarcinoma.
- Chronic Familial NeutropeniaDr. Alter isAdvanced. Learn about Chronic Familial Neutropenia.
- EGFR Positive Lung CancerDr. Alter isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Adrenal CancerDr. Alter isExperienced. Learn about Adrenal Cancer.
- Adult Immune ThrombocytopeniaDr. Alter isExperienced. Learn about Adult Immune Thrombocytopenia.
- Anal CancerDr. Alter isExperienced. Learn about Anal Cancer.
- Anaplastic Thyroid CancerDr. Alter isExperienced. Learn about Anaplastic Thyroid Cancer.
- AnemiaDr. Alter isExperienced. Learn about Anemia.
- Beta ThalassemiaDr. Alter isExperienced. Learn about Beta Thalassemia.
